PRMT7 and non-small cell lung carcinoma: Consistent with these findings, clinical analysis revealed significant co-upregulation of both PRMT7 and SOX9 in NSCLC specimens relative to adjacent normal tissues, with elevated levels of either protein correlating with diminished patient survival.